ADIPOQ and endothelial dysfunction: Therefore, it is possible that the observed depletion of adiponectin from adiposomes may limit systemic bioavailability or disrupt its delivery to endothelial cells [37,38], thereby contributing to the endothelial dysfunction characteristic of obese individuals.